[TOVX] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
31-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -525.18%
YoY- -278.84%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 0 0 0 0 -972 620 52 -
PBT -11,297 -6,480 -4,225 -11,893 -2,662 -863 -1,104 47.31%
Tax -411 -621 -49 180 541 18 11 -
NP -10,982 -6,480 -4,224 -12,066 -3,185 -871 -1,114 46.40%
Tax Rate - - - - - - - -
Total Cost 10,982 6,480 4,224 12,066 2,213 1,490 1,166 45.29%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 0.00 0.00 0.00 0.00 327.60 -140.49 -2,141.75 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -42.28 -31.19 -30.32 -102.55 -37.64 -13.08 -18.18 15.09%
EPS Diluted -42.28 -31.19 -25.40 -95.20 -35.62 -13.06 -18.11 15.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.